Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $343.64 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $121.85 | 1 | $0 (2018) |
| AbbVie, Inc. | $98.35 | 1 | $0 (2018) |
| Allergan Inc. | $59.92 | 4 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $32.66 | 2 | $0 (2017) |
| Janssen Biotech, Inc. | $15.85 | 1 | $0 (2017) |
| ACADIA Pharmaceuticals Inc | $15.01 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $220.20 | 2 | Amgen Inc. ($121.85) |
| 2017 | $123.44 | 8 | Allergan Inc. ($59.92) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/06/2018 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $121.85 | General |
| Category: Neuroscience | ||||||
| 05/17/2018 | AbbVie, Inc. | Duopa (Drug) | Food and Beverage | In-kind items and services | $98.35 | General |
| Category: Neuroscience | ||||||
| 05/11/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: NEUROSCIENCE | ||||||
| 04/21/2017 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: PDP | ||||||
| 04/12/2017 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $13.73 | General |
| 03/15/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET XR | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/01/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $10.93 | General |
| Category: NEUROSCIENCE | ||||||
| 03/01/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $10.44 | General |
| Category: NEUROSCIENCE | ||||||
| 02/14/2017 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Immunology | ||||||
| 01/23/2017 | Allergan Inc. | BOTOX CHRONIC MIGRAINE (Drug) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: ANTI-MIGRAINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 103 | 120 | $47,320 | $6,804 |
| 2022 | 3 | 97 | 138 | $43,222 | $6,268 |
| 2021 | 2 | 97 | 136 | $35,750 | $5,207 |
| 2020 | 5 | 92 | 108 | $33,706 | $4,517 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 37 | 52 | $19,390 | $3,054 | 15.7% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 34 | 36 | $15,660 | $2,142 | 13.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 19 | 19 | $9,215 | $1,130 | 12.3% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 13 | 13 | $3,055 | $477.62 | 15.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 50 | 82 | $29,110 | $4,397 | 15.1% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 33 | 42 | $9,660 | $1,228 | 12.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Facility | 2022 | 14 | 14 | $4,452 | $642.71 | 14.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 40 | 53 | $17,490 | $2,807 | 16.1% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 57 | 83 | $18,260 | $2,399 | 13.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 16 | 21 | $6,355 | $1,178 | 18.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 28 | 28 | $8,788 | $998.37 | 11.4% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 19 | 30 | $6,524 | $851.38 | 13.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 15 | 15 | $7,452 | $814.01 | 10.9% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Facility | 2020 | 14 | 14 | $4,587 | $675.19 | 14.7% |
About Dr. Joav Kofman, M.D
Dr. Joav Kofman, M.D is a Neurology healthcare provider based in Grafton, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972548840.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joav Kofman, M.D has received a total of $343.64 in payments from pharmaceutical and medical device companies, with $220.20 received in 2018. These payments were reported across 10 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($343.64).
As a Medicare-enrolled provider, Kofman has provided services to 389 Medicare beneficiaries, totaling 502 services with total Medicare billing of $22,795. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location Grafton, WI
- Active Since 06/17/2006
- Last Updated 11/30/2023
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1972548840
Products in Payments
- Aimovig (Biological) $121.85
- Duopa (Drug) $98.35
- NAMZARIC (Drug) $39.91
- BOTOX CHRONIC MIGRAINE (Drug) $20.01
- JANUVIA (Drug) $18.93
- STELARA (Biological) $15.85
- NUPLAZID (Drug) $15.01
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.